[HTML][HTML] Pharmacokinetic Interaction Between Olaparib and Regorafenib in an Animal Model
D Szkutnik-Fiedler, A Karbownik, F Otto… - …, 2024 - pmc.ncbi.nlm.nih.gov
Background: Olaparib (OLA) and regorafenib (REG) are metabolized by the CYP3A4
isoenzyme of cytochrome P450. Both drugs are also substrates and inhibitors of the …
isoenzyme of cytochrome P450. Both drugs are also substrates and inhibitors of the …
Pharmacokinetic drug–drug interaction between olaparib and apixaban: a case report
M Berge, JS Giraud, S De Percin, A Puszkiel… - Cancer Chemotherapy …, 2024 - Springer
The use of apixaban, a direct oral anticoagulant (DOAC), is growing in oncology but
pharmacokinetic drug–drug interactions (P-DDIs) with moderate or strong cytochrome P450 …
pharmacokinetic drug–drug interactions (P-DDIs) with moderate or strong cytochrome P450 …